Cargando…
Gemcabene, a first-in-class lipid-lowering agent in late-stage development, down-regulates acute-phase C-reactive protein via C/EBP-δ-mediated transcriptional mechanism
Inflammation plays a key role in setting the stage leading to atherosclerosis progression, and high-sensitivity C-reactive protein (CRP) has been recognized as a predictor of cardiovascular risk. As a monotherapy and in combination with statins, gemcabene markedly reduced CRP in humans. Present inve...
Autores principales: | Srivastava, Rai Ajit K., Cornicelli, Joseph A., Markham, Bruce, Bisgaier, Charles L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223808/ https://www.ncbi.nlm.nih.gov/pubmed/29644527 http://dx.doi.org/10.1007/s11010-018-3353-5 |
Ejemplares similares
-
Gemcabene, a First-in-Class Hypolipidemic Small Molecule in Clinical Development, Attenuates Osteoarthritis and Pain in Animal Models of Arthritis and Pain
por: Srivastava, Rai A. K., et al.
Publicado: (2018) -
Comparative Evaluation of Gemcabene and Peroxisome Proliferator–Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator–Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease
por: Bisgaier, Charles L., et al.
Publicado: (2018) -
Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH
por: Oniciu, Daniela Carmen, et al.
Publicado: (2018) -
C/EBPδ Gene Targets in Human Keratinocytes
por: Borrelli, Serena, et al.
Publicado: (2010) -
The Many Faces of C/EBPδ and their Relevance for Inflammation and Cancer
por: Balamurugan, Kuppusamy, et al.
Publicado: (2013)